Literature DB >> 9973407

Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.

W P Thayer1, L Ignatowicz, D A Weber, P E Jensen.   

Abstract

The class II-associated invariant chain peptide (CLIP) region of invariant chain (Ii) is believed to play a critical role in the assembly and transport of MHC class II alphabetaIi complexes through its interaction with the class II peptide-binding site. The role of the CLIP sequence was investigated by using mutant Ii molecules with altered affinity for the DR1 peptide-binding site. Both high- and low-affinity mutants were observed to efficiently assemble with DR1 and mediate transport to endosomal compartments in COS cell transfectants. Using N- and C-terminal truncations, a region adjacent to CLIP within Ii(103-118) was identified that can complement loss of affinity for the peptide-binding site in mediating efficient assembly of alphabetaIi. A C-terminal fragment completely lacking the CLIP region, Ii(103-216), was observed binding stably to class II molecules in immunoprecipitation studies and experiments with purified proteins. The Ii(103-118) region was required for this binding, which occurs through interactions outside of the alphabeta peptide-binding groove. We conclude that strong interactions involving Ii(103-118) and other regions of Ii cooperate in the assembly of functional alphabetaIi under conditions where CLIP has little or no affinity for the class II peptide-binding site. Our results support the hypothesis that the CLIP sequence has evolved to avoid high-stability interactions with the peptide-binding sites of MHC class II molecules rather than as a promiscuous binder with moderate affinity for all class II molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.

Authors:  F Bischof; W Wienhold; C Wirblich; G Malcherek; O Zevering; A M Kruisbeek; A Melms
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

3.  Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.

Authors:  Elisabeth Sievers; Jürgen Neumann; Martin Raftery; Günther SchOnrich; Anna Maria Eis-Hübinger; Norbert Koch
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 4.  Association of intracellular proteins with folded major histocompatibility complex class I molecules.

Authors:  Chantey R Morris; Adrian J Reber; Jason L Petersen; Shanna E Vargas; Joyce C Solheim
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly.

Authors:  Mark Anczurowski; Yuki Yamashita; Munehide Nakatsugawa; Toshiki Ochi; Yuki Kagoya; Tingxi Guo; Chung-Hsi Wang; Muhammed A Rahman; Kayoko Saso; Marcus O Butler; Naoto Hirano
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

6.  The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.

Authors:  Maryse Cloutier; Jean-Simon Fortin; Jacques Thibodeau
Journal:  BMC Immunol       Date:  2021-08-12       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.